Nipple-Sparing Mastectomy After Neoadjuvant Chemotherapy: Definitive Results with a Long-Term Follow-Up Evaluation
CONCLUSIONS: The study data definitively confirm that NSM is safe even after NACT, with good cosmetic results and complications comparable with those in the primary surgery setting. Tumor stage and age were the only independent factors for local relapse. Patients with pCR enjoyed optimal locoregional control.PMID:36598627 | DOI:10.1245/s10434-022-13035-5
Source: Cancer Control - Category: Cancer & Oncology Authors: Emanuele Zarba Meli Anna De Santis Giuliana Cortese Elena Manna Tiziana Mastropietro Massimo La Pinta Andrea Loreti Floriana Arelli Paola Scavina Mauro Minelli Angela Damiana Andrulli Leopoldo Costarelli Laura Broglia Tatiana Ponzani Lucio Fortunato Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Damiana | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Paget Disease of the Nipple | Paget's Disease | Study | Women